Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: Frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1)

被引:23
作者
Badr, KM
Nolen, JDL
Derose, PB
Cohen, C
机构
[1] Menia Univ, Minia Fac Med, Dept Urol, Cairo, Egypt
[2] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
schistosomiasis; urinary bladder carcinoma; squamous cell carcinoma; prognostic markers; proliferation; apoptosis; mutant p53; HER2/neu (c-erb-B-2);
D O I
10.1016/j.humpath.2003.10.006
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Muscle invasion is the usual presentation of schistosomal squamous cell carcinoma of the urinary bladder. It is unclear whether this invasive behavior is secondary to the aggressive nature of the disease or to delay in diagnosis. Fixed paraffin-embedded hematoxylin and eosin-stained sections of 15 cystectomy specimens from 15 patients (14 males, I female) (age range, 40 to 67 years), histologically confirmed as schistosomal squamous cell carcinoma, were assessed for grade (G1, n=3; G2, n=7; G3, n=5) and pathological stage (PT category: PT2, n=4; PT3a, n=9; PT3b, n=2). Immunostaining was performed for mutant p53, bcl-2, HER2/neu, and MIB-1 (proliferation), using steam antigen retrieval and an avidin-biotin complex method. Frequency of strong immunoreactivity was high for mutant p53 (73%) and MIB-1 (87% intermediate or high) but low for bcl-2 (20%) and HER2/neu (27%). There was no significant correlation of any of the four markers with either grade or stage. Hence, schistosomal bladder squamous cell carcinoma is felt to be an aggressive carcinoma de novo. The high frequency of mutant p53 expression (73%) and an intermediate to high proliferation index (87%) suggests this. The lack of correlation between histological grade and all four markers studied suggests that grading is not of prognostic value.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 38 条
[11]  
JAHNSON S, 1995, EUR UROL, V28, P135
[12]  
JUNG I, 2002, CANC CONTROL, V7, P325
[13]  
KAMEL D, 1994, VIRCHOWS ARCH, V424, P349, DOI 10.1007/BF00190555
[14]   Expression of bcl-2 and bcl-X in bladder cancer [J].
Kirsh, EJ ;
Baunoch, DA ;
Stadler, WM .
JOURNAL OF UROLOGY, 1998, 159 (04) :1348-1353
[15]   The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer [J].
Korkolopoulou, P ;
Christodoulou, P ;
Kapralos, P ;
Exarchakos, M ;
Bisbiroula, A ;
Hadjiyannakis, M ;
Georgountzos, C ;
Thomas-Tsagli, E .
PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (11-12) :767-775
[16]   Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters [J].
Koyuncuoglu, M ;
Kargi, A ;
Cingöz, S ;
Kirkali, Z .
CANCER LETTERS, 1998, 126 (02) :143-148
[17]   Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder [J].
Li, BY ;
Kanamaru, H ;
Noriki, S ;
Yamaguchi, T ;
Fukuda, M ;
Okada, K .
UROLOGICAL RESEARCH, 1998, 26 (04) :235-241
[18]   EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN TRANSITIONAL CELL BLADDER-CANCER [J].
LIPPONEN, P .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) :749-753
[19]   INTERRELATIONSHIP BETWEEN EXPRESSION OF P53, PROLIFERATING CELL NUCLEAR ANTIGEN AND C-ERBB-2 IN BLADDER-CANCER [J].
LIPPONEN, PK .
PATHOBIOLOGY, 1993, 61 (3-4) :178-182
[20]   Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours [J].
Lipponen, PK ;
Aaltomaa, S ;
Eskelinen, M .
HISTOPATHOLOGY, 1996, 28 (02) :135-140